Product
HepA-I
2 clinical trials
3 indications
Indication
PoliomyelitisIndication
PolioIndication
Hepatitis AClinical trial
Open-labeled, Randomized, Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of Booster Dose of sIPV Co-administered With MMR and HepA-I.Status: Not yet recruiting, Estimated PCD: 2025-02-10
Clinical trial
Phase IV Study of Evaluating Immunogenicity and Safety of Concomitant Administration of Sabin-strain-based Inactivated Poliovirus Vaccine (Vero Cells) and Freeze-dried Live-attenuated Hepatitis A Vaccine or Inactivated Hepatitis A VaccineStatus: Not yet recruiting, Estimated PCD: 2026-08-15